← Back to all stories
Affordable daily medication brings new hope for easing long COVID fatigue
Photo: Towfiqu barbhuiya / Unsplash
A clinical trial of nearly 400 adults found that fluvoxamine, a widely available and low-cost antidepressant, significantly reduces fatigue and improves quality of life for those with long COVID. This discovery marks one of the first successful drug treatments for the highly disabling condition, offering a practical path forward for millions of patients.
A clinical trial of nearly 400 adults found that fluvoxamine, a widely available and low-cost antidepressant, significantly reduces fatigue and improves quality of life for those with long COVID. This discovery marks one of the first successful drug treatments for the highly disabling condition, offering a practical path forward for millions of patients.